4521.T
Price:
$3795
Market Cap:
$145.74B
Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. It offers pharmaceutical products and medical devices, such as Clenafin, a topical treatment for onychomycosis; Artz, an anti-osteoarthritis agent; Seprafilm, a semitransparent film-type absorbable adhesion barrier, which is applied to damaged tissue; Fiblast, a spray-on drug for the treatment of pressure ulcers and other skin ulcers; Regroth, a medicinal product for periodontal regeneration; and Hernicore for the treatment of lumbar disc herniation. The company also provides Adofeed, a pain- and inflammation-relieving plaster; Ebrantil for the treatm...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2001-01-01
Stock Exchange
JPX
Ticker
4521.T
According to Kaken Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 7.01. This represents a change of -50.59% compared to the average of 14.19 of the last 4 quarters.
The mean historical PE Ratio of Kaken Pharmaceutical Co., Ltd. over the last ten years is 15.38. The current 7.01 PE Ratio has changed 4.46% with respect to the historical average. Over the past ten years (40 quarters), 4521.T's PE Ratio was at its highest in in the March 2016 quarter at 69.84. The PE Ratio was at its lowest in in the March 2022 quarter at -52.77.
Average
15.38
Median
13.34
Minimum
10.16
Maximum
25.52
Discovering the peaks and valleys of Kaken Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 67.33%
Maximum Annual PE Ratio = 25.52
Minimum Annual Increase = -44.25%
Minimum Annual PE Ratio = 10.16
Year | PE Ratio | Change |
---|---|---|
2024 | 16.30 | -36.11% |
2023 | 25.52 | 64.95% |
2022 | 15.47 | 23.97% |
2021 | 12.48 | 22.78% |
2020 | 10.16 | -11.68% |
2019 | 11.51 | -13.77% |
2018 | 13.35 | 13.88% |
2017 | 11.72 | -12.14% |
2016 | 13.34 | -44.25% |
2015 | 23.93 | 67.33% |
The current PE Ratio of Kaken Pharmaceutical Co., Ltd. (4521.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
19.10
5-year avg
15.99
10-year avg
15.38
Kaken Pharmaceutical Co., Ltd.’s PE Ratio is less than Tsumura & Co. (10.03), less than Nippon Shinyaku Co., Ltd. (7.63), greater than Sumitomo Pharma Co., Ltd. (-1.96), less than Shionogi & Co., Ltd. (11.26), less than Hisamitsu Pharmaceutical Co., Inc. (14.52),
Company | PE Ratio | Market cap |
---|---|---|
10.03 | $271.37B | |
7.63 | $231.85B | |
-1.96 | $344.85B | |
11.26 | $1.90T | |
14.52 | $314.76B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kaken Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kaken Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Kaken Pharmaceutical Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Kaken Pharmaceutical Co., Ltd. (4521.T)?
What is the highest PE Ratio for Kaken Pharmaceutical Co., Ltd. (4521.T)?
What is the 3-year average PE Ratio for Kaken Pharmaceutical Co., Ltd. (4521.T)?
What is the 5-year average PE Ratio for Kaken Pharmaceutical Co., Ltd. (4521.T)?
How does the current PE Ratio for Kaken Pharmaceutical Co., Ltd. (4521.T) compare to its historical average?